PhRMA Spent $59 Million on Search Ads
The drug industry lobbying group's paid search campaign targeted how Americans view prescription drug costs.
Updated on Nov. 5, 2026 in Advertising
Live Poll
Do you trust drug industry advertising about why prescription prices are high?
The lobbying group for the U.S. pharmaceutical industry, PhRMA, spent an estimated $59 million on search advertising over seven years, from 2019 through 2025. The campaign aimed to shape how Americans view prescription drug costs.
Why it matters
The spending surged around legislative and regulatory actions, including the start of Medicare drug price negotiations in 2023. The campaign shows how industry groups use paid search to shape public perception during policy debates over drug pricing.
PhRMA used more than 283,500 distinct keywords to generate 17.1 million paid visits from 2019 through 2025, with the spending modeled in a new analysis. The analysis does not address how the campaign's reach compared with other industry advertising or what effect it had on public views of drug costs.
The players
PhRMA
The Pharmaceutical Research and Manufacturers of America is the lobbying group for the U.S. pharmaceutical industry, representing major drugmakers in federal policy debates.
Pharmacy benefit managers
Pharmacy benefit managers are intermediaries that administer prescription drug benefits for health plans and employers, and they have been a frequent target of criticism from drugmakers over costs.
The details
The campaign used more than 283,500 distinct keywords in paid search, with about $32 million tied to searches about insurance and health plans and about $28 million directing users to web pages and domains criticizing pharmacy benefit managers.
Timeline
2019 through 2025: PhRMA's paid search campaign generated 17.1 million visits.
2023: Medicare drug price negotiations began, and ad spending surged.
Market Landscape
The campaign's timing tracks the start of Medicare drug price negotiations in 2023, when federal pricing policy moved from proposal to implementation. Industry groups have increasingly relied on paid search and targeted advertising to shape public debate over drug costs during such regulatory moments.
Americans who follow drug pricing debates may encounter industry-funded search results and advertising that frame the issue in particular ways. Readers can compare sources when researching prescription costs, since paid search placements may favor the advertiser's perspective.
The takeaway
Paid search can quietly steer public understanding of complex policy issues like drug pricing. Checking who funds the top search results is a practical step for anyone researching prescription costs.
Further reading
Explore more on the Advertising industry in the United States.
Source note: This article includes information reported by STAT.
Live Poll
Do you trust drug industry advertising about why prescription prices are high?
